General Information of Drug Off-Target (DOT) (ID: OTCL5EE8)

DOT Name Uncharacterized protein C17orf67 (C17ORF67)
Gene Name C17ORF67
Related Disease
Androgen insensitivity syndrome ( )
Atypical hemolytic uremic syndrome ( )
Inflammatory bowel disease ( )
Ankylosing spondylitis ( )
Crohn disease ( )
Psoriasis ( )
Sclerosing cholangitis ( )
Ulcerative colitis ( )
UniProt ID
CQ067_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF15076
Sequence
MKTLPVLVLSLTLLTVFSETSPILTEKQAKQLLRSRRQDRPSKPGFPDEPMREYMHHLLA
LEHRAEEQFLEHWLNPHCKPHCDRNRIHPV

Molecular Interaction Atlas (MIA) of This DOT

8 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Androgen insensitivity syndrome DISUZBBO Strong Genetic Variation [1]
Atypical hemolytic uremic syndrome DIS6FUDJ Strong CausalMutation [2]
Inflammatory bowel disease DISGN23E moderate Genetic Variation [3]
Ankylosing spondylitis DISRC6IR Limited Genetic Variation [4]
Crohn disease DIS2C5Q8 Limited Genetic Variation [4]
Psoriasis DIS59VMN Limited Genetic Variation [4]
Sclerosing cholangitis DIS7GZNB Limited Genetic Variation [4]
Ulcerative colitis DIS8K27O Limited Genetic Variation [4]
------------------------------------------------------------------------------------
⏷ Show the Full List of 8 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
4 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Acetaminophen DMUIE76 Approved Acetaminophen increases the expression of Uncharacterized protein C17orf67 (C17ORF67). [5]
Methotrexate DM2TEOL Approved Methotrexate decreases the expression of Uncharacterized protein C17orf67 (C17ORF67). [7]
Permethrin DMZ0Q1G Approved Permethrin decreases the expression of Uncharacterized protein C17orf67 (C17ORF67). [8]
PMID28460551-Compound-2 DM4DOUB Patented PMID28460551-Compound-2 increases the expression of Uncharacterized protein C17orf67 (C17ORF67). [10]
------------------------------------------------------------------------------------
2 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Arsenic DMTL2Y1 Approved Arsenic affects the methylation of Uncharacterized protein C17orf67 (C17ORF67). [6]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene increases the methylation of Uncharacterized protein C17orf67 (C17ORF67). [9]
------------------------------------------------------------------------------------

References

1 Association between genetic determinants of peak height velocity during puberty and predisposition to adolescent idiopathic scoliosis.Spine (Phila Pa 1976). 2013 May 20;38(12):1034-9. doi: 10.1097/BRS.0b013e318287fcfd.
2 Phenotypic expansion of DGKE-associated diseases.J Am Soc Nephrol. 2014 Jul;25(7):1408-14. doi: 10.1681/ASN.2013080886. Epub 2014 Feb 7.
3 Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations.Nat Genet. 2015 Sep;47(9):979-986. doi: 10.1038/ng.3359. Epub 2015 Jul 20.
4 Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci.Nat Genet. 2016 May;48(5):510-8. doi: 10.1038/ng.3528. Epub 2016 Mar 14.
5 Multiple microRNAs function as self-protective modules in acetaminophen-induced hepatotoxicity in humans. Arch Toxicol. 2018 Feb;92(2):845-858.
6 Prenatal arsenic exposure and the epigenome: identifying sites of 5-methylcytosine alterations that predict functional changes in gene expression in newborn cord blood and subsequent birth outcomes. Toxicol Sci. 2015 Jan;143(1):97-106. doi: 10.1093/toxsci/kfu210. Epub 2014 Oct 10.
7 Global molecular effects of tocilizumab therapy in rheumatoid arthritis synovium. Arthritis Rheumatol. 2014 Jan;66(1):15-23.
8 Exposure to Insecticides Modifies Gene Expression and DNA Methylation in Hematopoietic Tissues In Vitro. Int J Mol Sci. 2023 Mar 26;24(7):6259. doi: 10.3390/ijms24076259.
9 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
10 Cell-based two-dimensional morphological assessment system to predict cancer drug-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes. Toxicol Appl Pharmacol. 2019 Nov 15;383:114761. doi: 10.1016/j.taap.2019.114761. Epub 2019 Sep 15.